secwatch.observer — SEC 8-K summary
======================================

Issuer:     Nuvation Bio Inc. (NUVB)
CIK:        0001811063
Form:       8-K
Filed at:   2022-01-10T23:59:59+00:00
Accession:  0001193125-22-004997
Event type: other
Sentiment:  neutral
Materiality: 0.20
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nuvation Bio to present at JPM 2022; no specific financial or pipeline updates disclosed
--------------------------------------------------------------------------------

- Company conducting investor meetings at 40th Annual J.P. Morgan Healthcare Conference starting Jan 10, 2022.
- Slide presentation furnished as Exhibit 99.1 contains only a title slide; no detailed data available.
- No earnings, clinical trial results, or guidance changes announced in the filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1811063/000119312522004997/0001193125-22-004997-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1811063/000119312522004997/d144679d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-004997

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer